• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍患者共病诊断时间的社会和多基因风险因素:全表型生存分析

Social and Polygenic Risk Factors for Time to Comorbid Diagnoses in Individuals with Substance Use Disorders: A Phenome-Wide Survival Analysis.

作者信息

Barr Peter B, Neale Zoe E, Bigdeli Tim B, Chatzinakos Chris, Harvey Philip D, Peterson Roseann E, Meyers Jacquelyn L

机构信息

SUNY Downstate Health Sciences University, Department of Psychiatry and Behavioral Sciences.

SUNY Downstate Health Sciences University, Institute for Genomics in Health.

出版信息

medRxiv. 2024 Dec 14:2024.12.13.24319000. doi: 10.1101/2024.12.13.24319000.

DOI:10.1101/2024.12.13.24319000
PMID:39711727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11661425/
Abstract

IMPORTANCE

Persons with substance use disorders (SUD) often suffer from additional comorbidities, including psychiatric conditions and physical health problems. Researchers have explored this overlap in electronic health records (EHR) using phenome wide association studies (PheWAS) to characterize how different indicators are related to all conditions in an individual's EHR. However, analyses have been largely cross-sectional in nature.

OBJECTIVE

To characterize whether various social and genetic risk factors are associated with time to comorbid diagnoses in electronic health records (EHR) after the first diagnosis of SUD.

DESIGN

Leveraging those with EHR and whole-genome sequencing data in All of Us (N = 287,012), we explored whether social determinants of health are associated with lifetime risk of SUD. Next, within those with a diagnosed SUD (N = 17,460), we examined whether polygenic scores (PGS) were associated with time to comorbid diagnoses performing a phenome-wide survival analysis.

SETTING

Participating health care organizations across the United States.

PARTICIPANTS

Participants in the All of Us Research Program with available EHR and genomic data.

EXPOSURES

Social determinants of health and polygenic scores (PGS) for psychiatric and substance use disorders.

MAIN OUTCOMES AND MEASURES

Phecodes for diagnoses derived from International Statistical Classification of Diseases, Ninth and Tenth Revisions, Clinical Modification, codes from EHR.

RESULTS

Multiple social and demographic risk factors were associated with lifetime SUD diagnosis. Most strikingly, those reporting an annual income <$10K had 4.5 times the odds of having an SUD diagnosis compared to those reporting $100-$150K annually (OR = 4.48, 95% CI = 4.01, 5.01). PGSs for alcohol use disorders, schizophrenia, and post-traumatic stress disorder were associated with time to their respective diagnoses (HR = 1.10, 95% CI = 1.06, 1.14; HR = 1.13, 95% CI = 1.06, 1.20; HR = 1.15, 95% CI = 1.08, 1.22). A PGS for ever-smoking was associated with time to subsequent smoking related comorbidities and additional SUD diagnoses HR = 1.6 to 1.16).

CONCLUSIONS AND RELEVANCE

Social determinants, especially those related to income have profound associations with lifetime SUD risk. Additionally, PGS may include information related to outcomes above and beyond lifetime risk, including timing and severity.

摘要

重要性

患有物质使用障碍(SUD)的人通常还患有其他合并症,包括精神疾病和身体健康问题。研究人员利用全表型关联研究(PheWAS)在电子健康记录(EHR)中探索了这种重叠情况,以描述不同指标与个体EHR中的所有病症之间的关系。然而,分析在很大程度上本质上是横断面研究。

目的

描述在首次诊断SUD后,各种社会和遗传风险因素是否与电子健康记录(EHR)中共病诊断的时间相关。

设计

利用“我们所有人”项目中拥有EHR和全基因组测序数据的人群(N = 287,012),我们探讨了健康的社会决定因素是否与SUD的终生风险相关。接下来,在已诊断患有SUD的人群(N = 17,460)中,我们通过进行全表型生存分析,研究多基因评分(PGS)是否与共病诊断时间相关。

设置

美国各地参与的医疗保健机构。

参与者

“我们所有人”研究项目中拥有可用EHR和基因组数据的参与者。

暴露因素

健康的社会决定因素以及精神疾病和物质使用障碍的多基因评分(PGS)。

主要结局和测量指标

源自《国际疾病分类》第九版和第十版临床修订本的诊断phecode,以及EHR中的代码。

结果

多种社会和人口风险因素与终生SUD诊断相关。最引人注目的是,报告年收入低于1万美元的人患SUD诊断的几率是报告年收入10万至15万美元者的4.5倍(OR = 4.48,95% CI = 4.01,5.01)。酒精使用障碍、精神分裂症和创伤后应激障碍的PGS与各自诊断的时间相关(HR = 1.10,95% CI = 1.06,1.14;HR = 1.13,95% CI = 1.06,1.20;HR = 1.15,95% CI = 1.08,1.22)。曾经吸烟的PGS与随后吸烟相关合并症和额外SUD诊断的时间相关(HR = 1.6至1.16)。

结论及意义

社会决定因素,尤其是与收入相关的因素,与终生SUD风险有密切关联。此外,PGS可能包含与终生风险之外的结局相关的信息,包括发病时间和严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/6be68c2a8f1b/nihpp-2024.12.13.24319000v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/aae4f1b7f8c9/nihpp-2024.12.13.24319000v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/8c8237001f1f/nihpp-2024.12.13.24319000v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/6be68c2a8f1b/nihpp-2024.12.13.24319000v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/aae4f1b7f8c9/nihpp-2024.12.13.24319000v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/8c8237001f1f/nihpp-2024.12.13.24319000v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40c/11661425/6be68c2a8f1b/nihpp-2024.12.13.24319000v1-f0003.jpg

相似文献

1
Social and Polygenic Risk Factors for Time to Comorbid Diagnoses in Individuals with Substance Use Disorders: A Phenome-Wide Survival Analysis.物质使用障碍患者共病诊断时间的社会和多基因风险因素:全表型生存分析
medRxiv. 2024 Dec 14:2024.12.13.24319000. doi: 10.1101/2024.12.13.24319000.
2
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort.百万退伍军人计划队列中去抑制行为风险的相关因素。
JAMA Psychiatry. 2024 Feb 1;81(2):188-197. doi: 10.1001/jamapsychiatry.2023.4141.
3
Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration.比较电子健康记录数据中的物质使用障碍诊断率与退伍军人健康管理局各社会人口群组调查中报告的物质使用障碍流行率。
JAMA Netw Open. 2022 Jun 1;5(6):e2219651. doi: 10.1001/jamanetworkopen.2022.19651.
4
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.解开物质使用障碍的异质性:全基因组多基因评分的见解。
Transl Psychiatry. 2024 May 29;14(1):221. doi: 10.1038/s41398-024-02923-x.
5
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.患有和未患2型糖尿病的成年人的物质使用情况及精神诊断:电子健康记录数据的结果
Drug Alcohol Depend. 2015 Nov 1;156:162-169. doi: 10.1016/j.drugalcdep.2015.09.003. Epub 2015 Sep 12.
6
Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals.电子健康记录中与医疗共病相关的物质使用的遗传易感性在非裔和欧洲裔个体中。
Addict Biol. 2022 Jan;27(1):e13099. doi: 10.1111/adb.13099. Epub 2021 Oct 5.
7
INTEGRATING CLINICAL LABORATORY MEASURES AND ICD-9 CODE DIAGNOSES IN PHENOME-WIDE ASSOCIATION STUDIES.在全表型关联研究中整合临床实验室检测指标与ICD - 9编码诊断信息
Pac Symp Biocomput. 2016;21:168-79.
8
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes.创伤后应激障碍症状的遗传易感性及其与心血管代谢和呼吸系统结局的关系。
JAMA Psychiatry. 2024 Jan 1;81(1):34-44. doi: 10.1001/jamapsychiatry.2023.4127.
9
Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B.酒精使用障碍多基因评分与家族史及乙醇脱氢酶1B的比较。
JAMA Netw Open. 2024 Dec 2;7(12):e2452705. doi: 10.1001/jamanetworkopen.2024.52705.
10
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort.百万退伍军人计划队列中行为抑制相关风险因素
medRxiv. 2023 Jul 11:2023.03.22.23286865. doi: 10.1101/2023.03.22.23286865.

本文引用的文献

1
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.全基因组关联分析确定了 95 个风险位点,并为创伤后应激障碍的神经生物学提供了新见解。
Nat Genet. 2024 May;56(5):792-808. doi: 10.1038/s41588-024-01707-9. Epub 2024 Apr 18.
2
Genomic data in the All of Us Research Program.全美国研究计划中的基因组数据。
Nature. 2024 Mar;627(8003):340-346. doi: 10.1038/s41586-023-06957-x. Epub 2024 Feb 19.
3
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals.
多血统个体超过 100 万人的问题性饮酒使用的遗传学研究。
Nat Med. 2023 Dec;29(12):3184-3192. doi: 10.1038/s41591-023-02653-5. Epub 2023 Dec 7.
4
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications.多血统全基因组关联研究大麻使用障碍,深入了解疾病生物学和公共卫生影响。
Nat Genet. 2023 Dec;55(12):2094-2103. doi: 10.1038/s41588-023-01563-z. Epub 2023 Nov 20.
5
Polygenic scoring accuracy varies across the genetic ancestry continuum.多基因评分准确性在遗传祖先连续体上有所差异。
Nature. 2023 Jun;618(7966):774-781. doi: 10.1038/s41586-023-06079-4. Epub 2023 May 17.
6
FinnGen provides genetic insights from a well-phenotyped isolated population.FinnGen 为一个表型良好的隔离人群提供了遗传学方面的见解。
Nature. 2023 Jan;613(7944):508-518. doi: 10.1038/s41586-022-05473-8. Epub 2023 Jan 18.
7
Genetic diversity fuels gene discovery for tobacco and alcohol use.遗传多样性为烟草和酒精使用的基因发现提供了动力。
Nature. 2022 Dec;612(7941):720-724. doi: 10.1038/s41586-022-05477-4. Epub 2022 Dec 7.
8
Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts.物质使用障碍的临床、环境和遗传风险因素:跨多个队列描述综合效应。
Mol Psychiatry. 2022 Nov;27(11):4633-4641. doi: 10.1038/s41380-022-01801-6.
9
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System.美国退伍军人事务医疗保健系统中成年人精神分裂症、双相情感障碍和抑郁症多基因风险评分的外显率和多效性
JAMA Psychiatry. 2022 Sep 14;79(11):1092-101. doi: 10.1001/jamapsychiatry.2022.2742.
10
Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci.全基因组关联研究在欧洲和非洲血统个体中进行,以及阿片类药物使用障碍的多特征分析确定了 19 个独立的全基因组显著风险位点。
Mol Psychiatry. 2022 Oct;27(10):3970-3979. doi: 10.1038/s41380-022-01709-1. Epub 2022 Jul 25.